Get started
Author

Tatsuhiro Fujimiya

Observed names: TATSUHIRO FUJIMIYA, Tatsuhiro FUJIMIYA
ORCID: 0000-0001-8198-7465
Observed ORCID: 0000-0001-8198-7465
OpenAlex ID: A5017513121
Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis
2021 · Yuko Morino, Mitsushige Sugimoto, et al. · Frontiers in Pharmacology · 28
Pembrolizumab-induced secondary adrenal insufficiency due to adrenocorticotrophic hormone deficiency in a patient with non-small-cell lung carcinoma: a case report
2024 · Tatsuhiro Fujimiya, Kanako Azuma, et al. · Journal of Pharmaceutical Health Care and Sciences · 9
PDF
Successful continuance of CDK4/6 inhibitor treatment with palbociclib after abemaciclib-induced hepatotoxicity in breast cancer: a case report
2023 · Yuki Ozawa, Tatsuhiro Fujimiya, et al. · Anti-Cancer Drugs · 7
Risk Associated with Severe Hematological Toxicity in Patients with Urothelial Cancer Receiving Combination Chemotherapy of Gemcitabine and Cisplatin
2020 · Noriko Takahashi, Tomiko Sunaga, et al. · Chemotherapy · 5
Psychological barriers to the use of opioid analgesics for treating pain in patients with advanced recurrent cancer (BAROC): protocol for a multicentre cohort study
2022 · Takehiko Tsuno, Tatsuhiro Fujimiya, et al. · BMJ Open · 3
PDF
Case of Imatinib Susceptibility to CYP3A4-Mediated Drug–Drug Interactions in a Patient With Gastrointestinal Stromal Tumor
2022 · Tatsuhiro Fujimiya, Hideki Sugita, et al. · American Journal of Therapeutics · 1
Effect of the GSTM1 Null Genotype on Glutathione S-Transferase (GST) Activity in Patients with Non-Viral Liver Tumors
2016 · Tatsuhiro FUJIMIYA, Yasuna KOBAYASHI, et al. · The Showa University Journal of Medical Sciences · 1
PDF
Risk Factors for Niraparib-induced Severe Anemia in Japanese Patients With Ovarian Cancer: A Multicenter Study
2026 · YUKI OZAWA, HIROMU TANIGAWA, et al. · Anticancer Research
Works count: 8
Citation count: 53
H-index: 4
I10-index: 1
Year
Topic
Type